These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8878019)

  • 1. Hyperplastic mesothelial cells within abdominal lymph nodes: mimic of metastatic ovarian carcinoma and serous borderline tumor--a report of two cases associated with ovarian neoplasms.
    Clement PB; Young RH; Oliva E; Sumner HW; Scully RE
    Mod Pathol; 1996 Sep; 9(9):879-86. PubMed ID: 8878019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperplastic mesothelial cells in pelvic and abdominal lymph node sinuses mimicking metastatic ovarian microinvasive serous borderline tumor.
    Kir G; Eren S; Kir M
    Eur J Gynaecol Oncol; 2004; 25(2):236-8. PubMed ID: 15032291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
    Djordjevic B; Malpica A
    Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic serous borderline ovarian tumor in an internal mammary lymph node: a case report and review of the literature.
    Chamberlin MD; Eltabbakh GH; Mount SL; Leavitt BJ
    Gynecol Oncol; 2001 Jul; 82(1):212-5. PubMed ID: 11426990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian sertoli-leydig cell tumors with pseudoendometrioid tubules (pseudoendometrioid sertoli-leydig cell tumors).
    McCluggage WG; Young RH
    Am J Surg Pathol; 2007 Apr; 31(4):592-7. PubMed ID: 17414107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesothelial pelvic lymph node inclusions mimicking metastatic thyroid carcinoma.
    Cohn DE; Folpe AL; Gown AM; Goff BA
    Gynecol Oncol; 1998 Feb; 68(2):210-3. PubMed ID: 9514806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
    Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
    Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis.
    Kim HS; Yoon G; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS; Song SY
    Int J Clin Exp Pathol; 2015; 8(5):5318-26. PubMed ID: 26191233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible metaplastic origin of lymph node "metastases" in serous ovarian tumor of low malignant potential (borderline serous tumor).
    Kadar N; Krumerman M
    Gynecol Oncol; 1995 Dec; 59(3):394-7. PubMed ID: 8522262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian involvement by desmoplastic small round cell tumor with leydig cell hyperplasia showing an unusual immunophenotype (cytokeratin negative, calretinin and inhibin positive) mimicking poorly differentiated sertoli leydig cell tumor.
    Engohan-Aloghe C; Aubain Sommerhausen Nde S; Noël JC
    Int J Gynecol Pathol; 2009 Nov; 28(6):579-83. PubMed ID: 19851210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benign epithelial inclusions in pelvic lymph nodes. 2 case reports].
    Alvarado Cabrero I; Sosa Romero A
    Ginecol Obstet Mex; 2000 Feb; 68():77-81. PubMed ID: 10774109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
    Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Müllerian and mesothelial lymph node involvement in patients with borderline ovarian tumors.
    Eltabbakh GH; Mount SL
    J Reprod Med; 2011; 56(5-6):211-8. PubMed ID: 21682116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectopic mesothelial cell proliferation in cervical lymph nodes after severe ovarian hyperstimulation syndrome.
    van der Weiden RM; Meijers CJ; Hegt VN
    Fertil Steril; 2005 Mar; 83(3):739-41. PubMed ID: 15749507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-needle aspiration biopsy and intraoperative cytologic smear findings in a case of benign mesothelial-cell inclusions involving a lymph node: case report and review of the literature.
    Paull G; Mosunjac M
    Diagn Cytopathol; 2003 Sep; 29(3):163-6. PubMed ID: 12951686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases.
    Ordi J; Schammel DP; Rasekh L; Tavassoli FA
    Mod Pathol; 1999 Oct; 12(10):933-40. PubMed ID: 10530556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.